Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Primary cervical screening with high risk human papillomavirus testing: observational study.

Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, Smith J, Evans C, Giles T, Frew V, Tyler X, Sargent A, Parker J, Holbrook M, Hunt K, Tidbury P, Levine T, Smith D, Patnick J, Stubbs R, Moss S, Kitchener H.

BMJ. 2019 Feb 6;364:l240. doi: 10.1136/bmj.l240.

2.

A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).

Kitchener HC, Gittins M, Rivero-Arias O, Tsiachristas A, Cruickshank M, Gray A, Brabin L, Torgerson D, Crosbie EJ, Sargent A, Roberts C.

Health Technol Assess. 2016 Sep;20(68):1-138. doi: 10.3310/hta20680.

3.

Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study.

Flatley JE, Sargent A, Kitchener HC, Russell JM, Powers HJ.

BMC Cancer. 2014 Nov 3;14:803. doi: 10.1186/1471-2407-14-803.

4.

The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.

C Kitchener H, Canfell K, Gilham C, Sargent A, Roberts C, Desai M, Peto J.

Health Technol Assess. 2014 Apr;18(23):1-196. doi: 10.3310/hta18230.

5.

Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation.

Teschendorff AE, Jones A, Fiegl H, Sargent A, Zhuang JJ, Kitchener HC, Widschwendter M.

Genome Med. 2012 Mar 27;4(3):24.

6.

The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer.

Zhuang J, Jones A, Lee SH, Ng E, Fiegl H, Zikan M, Cibula D, Sargent A, Salvesen HB, Jacobs IJ, Kitchener HC, Teschendorff AE, Widschwendter M.

PLoS Genet. 2012 Feb;8(2):e1002517. doi: 10.1371/journal.pgen.1002517. Epub 2012 Feb 9. Erratum in: PLoS Genet. 2012 Mar;8(3). doi: 10.1371/annotation/35f168f3-c509-4b4f-b245-f6682325838e.

7.

Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews.

Almonte M, Silva Idos S, Asare A, Gilham C, Sargent A, Bailey A, Turner A, Desai M, Kitchener HC, Peto J.

J Med Virol. 2011 Jul;83(7):1238-46. doi: 10.1002/jmv.22085. Epub 2011 Apr 22.

PMID:
21520139
8.

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial.

Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, Desai M, Mather J, Turner A, Moss S, Peto J.

Eur J Cancer. 2011 Apr;47(6):864-71. doi: 10.1016/j.ejca.2011.01.008. Epub 2011 Feb 18.

PMID:
21334200
9.

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, Bailey A, Turner A, Moss S, Peto J.

Lancet Oncol. 2009 Jul;10(7):672-82. doi: 10.1016/S1470-2045(09)70156-1. Epub 2009 Jun 17. Erratum in: Lancet Oncol. 2009 Aug;10(8):748.

PMID:
19540162
10.

Potential applications of oral brush cytology with liquid-based technology: results from a cohort of normal oral mucosa.

Kujan O, Desai M, Sargent A, Bailey A, Turner A, Sloan P.

Oral Oncol. 2006 Sep;42(8):810-8. Epub 2006 Feb 3.

PMID:
16458571

Supplemental Content

Loading ...
Support Center